Pangasian, Ruben D.
HRN: 03-72-95 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/23/2024
CEFTRIAXONE 1G (VIAL)
05/23/2024
05/30/2024
IV
2g
OD
Prophylaxis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes